Treatment of multiple sclerosis in children and its challenges.
Though pediatric-onset multiple sclerosis (MS) is a rare disease, providers must be aware of the diagnosis, and of symptoms that herald demyelination, in order to initiate prompt workup and treatment in the appropriate clinical scenarios. Though children with MS do not have significant physical disability at onset, at least a third of patients have cognitive deficits at the time of diagnosis and demonstrate worsening cognitive functioning over time. Pediatric MS patients tend to have high relapse rates and high lesion volumes early in their disease course and warrant early initiation of disease modifying therapy. This review discusses the different treatment options available for pediatric patients with MS, emerging medications, and some of the challenges associated with treating this patient population.
Perelman School of Medicine at the University of Pennsylvania, Children's Hospital of Philadelphia, Division of Neurology, Philadelphia, PA 19104, United States. Electronic address: narulas@email.chop.edu.
Sona
S
Narula
Perelman School of Medicine at the University of Pennsylvania, Children's Hospital of Philadelphia, Division of Neurology, Philadelphia, PA 19104, United States.
Brenda
B
Banwell
D002648:Child; D006801:Humans; D009103:Multiple Sclerosis / Q000188:drug therapy*